EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell-Mediated Immunity Against Human Papillomavirus Infection: From Viral Clearance to Oncogenesis

Diana Savage, Jiafen Hu iD, Adam D Burgener, Afshin Raouf, Thomas T Murooka iD

Viruses · 2026

DOI: 10.3390/v18030362 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Diana Savage und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada. Hauptthemen laut MEDLINE: Papillomavirus Infections, Human Papillomavirus Viruses, Immunity, Cellular, Carcinogenesis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, CIHR, CancerCare Manitoba Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV), especially high-risk HPV types, is a significant public health concern due to its association with various cancers and increased risk of acquiring other sexually transmitted infections (STIs). In most cases, host immunity rapidly responds to and clears HPV infections, but persistent or latent infections can increase susceptibility to cancer. A better understanding of how HPV interacts with and evades the immune response is vital to understanding disease progression and guiding the next generation of vaccines and immunotherapies. This review article provides a comprehensive overview of the immune mechanisms involved in HPV infection, highlighting the roles of T cells and other immune subsets. We discuss the immune evasion strategies employed by HPV and subsequent modulation of the immune microenvironment. Additionally, we explore the current therapeutic landscape and emerging immunotherapeutic approaches under investigation. By unveiling the intricacies of the immune response to HPV, we may inform improved strategies for the treatment of HPV-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsHuman Papillomavirus VirusesImmunity, CellularCarcinogenesisHumansImmune EvasionAnimalsImmunotherapyT-LymphocytesPapillomaviridaeHost-Pathogen Interactions

Stichwörter der Autor:innen

T cell responsecell-mediated immunitycutaneous infectionhuman papillomavirusimmunotherapymucosal infection

Autor:innen und Institutionen

  • Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.
  • Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
  • Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
  • Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.

ORCID-Profile: Jiafen Hu, Thomas T Murooka

Förderung

  • NIH HHS
  • CIHR
  • CancerCare Manitoba Foundation
  • National Institute of Health
  • Jake Gittlen’s Laboratories for Cancer Research, and the Pathology Department Research Initiative
  • Canadian Institutes for Health Research

Zitieren

APA

Savage, D., Hu, J., Burgener, A. D., Raouf, A., & Murooka, T. T. (2026). Cell-Mediated Immunity Against Human Papillomavirus Infection: From Viral Clearance to Oncogenesis. Viruses. https://doi.org/10.3390/v18030362

Vancouver

Savage D, Hu J, Burgener AD, Raouf A, Murooka TT. Cell-Mediated Immunity Against Human Papillomavirus Infection: From Viral Clearance to Oncogenesis. Viruses. 2026. doi:10.3390/v18030362

BibTeX
@article{Savage2026,
  author = {Savage, Diana and Hu, Jiafen and Burgener, Adam D and Raouf, Afshin and Murooka, Thomas T},
  title = {Cell-Mediated Immunity Against Human Papillomavirus Infection: From Viral Clearance to Oncogenesis},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18030362}
}
Kostenlos starten →